Chemical Structure
Inhibitor
1560 Citations
Venetoclax
BT-0013
Venetoclax is a highly selective BCL-2 inhibitor approved for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).
Biological Activity
Directly binds BCL-2 with high affinity, displacing pro-apoptotic proteins and triggering mitochondrial apoptosis.
Product Specifications
CAS Number1257044-40-8
Molecular FormulaC45H50ClN7O7S
Molecular Weight868.44 g/mol
TargetBCL-2
PathwayApoptosis
Disease AreaCancer
IC50/EC50/KdKi: <0.01 nM (BCL-2)
Purity>99%
SolubilityDMSO: ≥10 mg/mL
Storage-20°C, desiccated
SpeciesHuman
Available Sizes
| Size | Price | |
|---|---|---|
| 5 mg | $80.00 | |
| 25 mg | $280.00 |